These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 16475491)

  • 41. Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis.
    Salmanpour R; Razmavar MR; Abtahi N
    Int J Dermatol; 2006 Sep; 45(9):1115-6. PubMed ID: 16961529
    [No Abstract]   [Full Text] [Related]  

  • 42. Comparison of miltefosine and meglumine antimoniate for the treatment of zoonotic cutaneous leishmaniasis (ZCL) by a randomized clinical trial in Iran.
    Mohebali M; Fotouhi A; Hooshmand B; Zarei Z; Akhoundi B; Rahnema A; Razaghian AR; Kabir MJ; Nadim A
    Acta Trop; 2007 Jul; 103(1):33-40. PubMed ID: 17586452
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa.
    Niamba P; Goumbri-Lompo O; Traoré A; Barro-Traoré F; Soudré RT
    Australas J Dermatol; 2007 Feb; 48(1):32-4. PubMed ID: 17222299
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device.
    Bogenrieder T; Lehn N; Landthaler M; Stolz W
    Dermatology; 2003; 206(3):269-72. PubMed ID: 12673089
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy of glucantime for treatment of cutaneous leishmaniasis in Central Iran.
    Mohammadzadeh M; Behnaz F; Golshan Z
    J Infect Public Health; 2013 Apr; 6(2):120-4. PubMed ID: 23537825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Old-world leishmaniasis of the auricle.
    Skevas A; Kastanioudakis I; Bai M; Kostoula A
    Lancet; 1997 Jan; 349(9044):28-9. PubMed ID: 8988123
    [No Abstract]   [Full Text] [Related]  

  • 47. Leishmaniasis recidiva cutis in New World cutaneous leishmaniasis.
    Oliveira-Neto MP; Mattos M; Souza CS; Fernandes O; Pirmez C
    Int J Dermatol; 1998 Nov; 37(11):846-9. PubMed ID: 9865872
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Refractory cutaneous leishmaniasis in an adolescent: initial manifestation of type 1 diabetes.
    Atabek ME; Pirgon O; Unal E
    J Infect; 2006 Oct; 53(4):290-1. PubMed ID: 16466661
    [No Abstract]   [Full Text] [Related]  

  • 49. Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia.
    Mlika RB; Hamida MB; Hammami H; Jannet SB; Badri T; Fenniche S; Mokhtar I
    Dermatol Ther; 2012; 25(6):615-8. PubMed ID: 23210761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A case with two unusual findings: cutaneous leishmaniasis presenting as panniculitis and pericarditis after antimony therapy.
    Eryilmaz A; Durdu M; Baba M; Bal N; Yiğit F
    Int J Dermatol; 2010 Mar; 49(3):295-7. PubMed ID: 20465667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy of CO(2) laser for treatment of anthroponotic cutaneous leishmaniasis, compared with combination of cryotherapy and intralesional meglumine antimoniate.
    Shamsi Meymandi S; Zandi S; Aghaie H; Heshmatkhah A
    J Eur Acad Dermatol Venereol; 2011 May; 25(5):587-91. PubMed ID: 20666876
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nodular lymphangitic subcutaneous dissemination after intralesional antimonial treatment for localized cutaneous leishmaniasis.
    Yébenes M; Cruz I; Cañavate C; Gilaberte M; Baena V; Pujol RM
    Clin Exp Dermatol; 2008 Mar; 33(2):142-4. PubMed ID: 18076691
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S; Marr JJ
    N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cryotherapy as an adjunct to systemic antimonials for cutaneous leishmaniasis in children.
    Stavropoulos PG; Papakonstantinou AM; Petropoulou H; Kontochristopoulos G; Katsambas A
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):765-6. PubMed ID: 16836528
    [No Abstract]   [Full Text] [Related]  

  • 55. Glucantime efficacy in the treatment of zoonotic cutaneous leishmaniasis.
    Pourmohammadi B; Motazedian MH; Handjani F; Hatam GH; Habibi S; Sarkari B
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):502-8. PubMed ID: 21706927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
    Soto J; Toledo J; Vega J; Berman J
    Am J Trop Med Hyg; 2005 Apr; 72(4):421-2. PubMed ID: 15827279
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis.
    Asilian A; Sadeghinia A; Faghihi G; Momeni A
    Int J Dermatol; 2004 Apr; 43(4):281-3. PubMed ID: 15090013
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutilating lupoid leishmaniasis: twelve years to make the diagnosis!
    Ghosn S; Dahdah MJ; Kibbi AG
    Dermatology; 2008; 216(2):187-9. PubMed ID: 18216488
    [No Abstract]   [Full Text] [Related]  

  • 59. [Treatment of localized cutaneous leishmaniasis].
    Buffet P; Caumes E; Gentilini M
    Ann Dermatol Venereol; 1994; 121(6-7):503-11. PubMed ID: 7702288
    [No Abstract]   [Full Text] [Related]  

  • 60. Slow-growing scaly erythematous plaque on the face and scalp of an elderly woman.
    Torres Garcia Y; Escutia Muñoz B; Botella Estrada R
    Actas Dermosifiliogr; 2013 Oct; 104(8):715-6. PubMed ID: 24011741
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.